Family · Pharmaceutical analytical standards
Granisetron
A serotonin 5-HT3 receptor antagonist, developed by British chemists in the mid-1980s and approved in 1991: it prevents nausea and vomiting caused by chemotherapy and radiotherapy. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards, nitrosamines and other impurities.
Did you know?Although it is a powerful antiemetic it does little for motion sickness: chemotherapy-induced vomiting runs through serotonin, while travel sickness follows other nerve pathways.
No product matches your search.
EDQM standards 3
The official European Pharmacopoeia standards for this family.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
